The involvement of the five thymidine (5T) variant in intron 8 of the cystic fibrosis membrane regulator (CFTR) gene in congenital bilateral absence of the vas deferens (CBAVD) phenotype has been extensively demonstrated. This variant leads to alternative splicing of the CFTR gene which results in a wild-type transcript and one without exon 9. Little is known about expression of the CFTR gene in the testis. We analysed the level of the aberrantly spliced transcripts in testicular biopsies and correlated it with disease expression. Quantitative RT-PCR analysis in testicular biopsies from control and CBAVD patients showed a correlation between the length of the IVS8-6(T) n tract and the level of alternatively spliced transcripts. Results from histological analysis also suggest an involvement of the alternative transcript in the spermatogenic status of patients, leading to a decreased number of mature sperm forms in the tubule.
INTRODUCTION
Cystic fibrosis (CF) is the most common autosomal recessive disease in populations of Caucasian origin (1) and is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene (2) (3) (4) . The CFTR gene encodes a transmembrane protein that forms a cyclic AMP-regulated chloride channel (5) . Reduction or loss of channel function as well as defective acidification of intracellular compartments in CF epithelia are responsible for the classical symptoms in CF (6) . However, wide variations in disease manifestations and severity are observed among affected CF patients, probably due to the multitude of disease-causing mutations in the CFTR gene and/or other factors (genetic and epigenetic).
In 97% of men with CF, bilateral congenital absence of the vas deferens (CBAVD) blocks the transport of spermatozoa from testicular or epididymal structures to the distal genital tract, resulting in azoospermia (7, 8) . Infertility due to CBAVD does not necessarily coincide with pulmonary or pancreatic manifestations of CF (9) .
CBAVD has been considered a primary form of CF, supported by the identification of mutations in the CFTR gene in the majority of these patients (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Three length variants of a polypyrimidine tract within the splice acceptor site in intron 8 of the CFTR gene have been found to be associated with a variable efficiency of exon 9 splicing (21) (22) . Due to the higher frequency of the five thymidine (5T) variant in CBAVD patients than in the general population (21 versus 5%), the 5T variant was classified as a CBAVD mutation with incomplete penetrance (15) . Several authors have studied the efficiency of exon 9 splicing related to the 5T allele in nasal epithelium versus vas deferens in healthy men (23) (24) and nasal and epididymal epithelium in some CBAVD patients (25) .
Controversial data about the testicular pathology involved in CF and CBAVD have been reported, from normal spermatogenesis (26) to occasional patients affected by a severely decreased spermatogenesis with abnormal sperm forms and reduced sperm number (7, 27) .
The principal aim of this study was to assess expression of the CFTR gene in the testis. We determined the level of the correctly spliced RNA transcripts and analysed the spermatogenic status of the patients under study.
RESULTS

CFTR analysis
Eight different mutations (R117H, L206W, V232D, ∆F508, G542X, 711+1G→T, D1270N and 2789+5G→A) were found in nine of the 12 CBAVD patients, yielding a CFTR mutation frequency of 75%. Three patients presented two CFTR mutations, with one of them homozygous for the V232D mutation. Four patients were heterozygous for one CFTR mutation and the IVS8-6(T) 5 allele. Two patients showed only one CFTR mutation and another the 5T allele. Only two patients, homozygous for the 7T allele, had no mutation after complete screening of the coding and flanking regions of the CFTR gene by means the methodology previously described (15, 28) . In the control group (azoospermic subjects without the CBAVD phenotype), one mutation (R334W) was identified among the six patients ( Table  1) . The genotypes for the polymorphic poly(T) tract of the IVS8-6(T) n locus in patient and control subjects are shown in Table 1 .
*To whom correspondence should be addressed. Tel: +34 93 260 7775; Fax: +34 93 260 77 76; Email: tcasals@iro.es Table 1 . CFTR genotype, IVS8-6 poly(T) allele and proportion of exon 9+ (E9+) and exon 9-(E9-) CFTR transcripts in testicular and epididymal biopsies
The mean proportion of E9+ and E9-CFTR transcripts is calculated as the mean of the proportions found for each sample. The standard deviation is also given in each case. n, number of replicate RT-PCR assays per sample.
Quantification of alternative CFTR transcripts in testicular biopsies
In order to determine the level of complete [exon 9+ (E9+)] and alternatively spliced [exon 9-(E9-)] transcripts expressed in testicular tissue, 18 biopsies were analysed by means of fluorescent RT-PCR analysis (Fig. 1) . Alternative splicing was observed in most of the samples analysed ( Table 1 ). The level of CFTR mRNA correctly transcribed in patients without the 5T allele ranged from 94 to 99%, both in the control and the CBAVD group. The proportion of E9+ CFTR mRNA was decreased in the five CBAVD individuals that carried the 5T allele. However, there was considerable variability among individuals, showing between 30 and 80% of CFTR mRNA correctly spliced. Epididymal biopsies of three CBAVD patients with the 7T allele were also analysed. We determined the proportion of E9+ and E9-CFTR transcripts in epididymal cells compared with the proportion found in testicular biopsies. A lower proportion of E9+ transcript was found in epididymis when compared with the testis of the same individual ( Table 1) .
Determination of spermatogenic status
Sixteen paraffin-embedded testicular specimens were available for histological analysis. Due to the heterogeneity in the aetiology of the samples that belonged to the control group (both obstructive and secretory patterns), we determined quantitative spermatogenesis only in the CBAVD group ( Table 2 ). The average number of specific germ cell types per tubule was determined from haematoxylin and eosin stained testicular sections (Fig. 2) . Statistical analysis was performed comparing the means of independent data and two different groups. Due to the similarity of variances (Levene's test, P > 0.05), a t-test for equality of variances was performed. The results of the study showed that while the mean number of spermatogoniae per tubule did not show differences between groups (16.5 in CBAVD 7T or 9T patients and 13.5 in the CBAVD 5T group; P = 0.26), the count of elongated spermatids per tubule was significantly different (P = 0.021) in non-5T (27.0) compared with 5T-bearing patients (15.6), suggesting a less efficient germ cell maturation process in the CBAVD patients that carry the 5T allele. The presence of one or two CFTR mutations in the absence of the 5T allele was not associated with a reduction in elongated spermatids per tubule (mean 26.8 from patients 7-10 and 13). The mean number ± SD of spermatogoniae/tubule and elongated spermatids/ tubule are given in each sample.
DISCUSSION
In the present report, we have confirmed testicular expression of the CFTR gene using RT-PCR analysis of testicular biopsies from CBAVD and infertile non-CBAVD patients. The CF mutation frequency of 75% in the studied group does not differ The size of the fragments is automatically determined by comparison with an internal standard DNA ladder GS-1000 (ST). E9+ fragments were 556 bp long and E9-were 376 bp. The relative quantities of the E9+ versus E9-transcripts (left corner) are determined by comparing the corresponding peak areas in each case. In (c) the E9+ peak, due to the high signal, resulted in two fragments, 2B and 3B. The total area of the E9+ peak in this case is calculated as the sum of the peak area results for the same minute.
from that previously published by our group (15) . We have found no CFTR mutations in three CBAVD individuals, which is consistent with the high heterogeneity of the Spanish CF population (28) and/or the presence of other factors leading to the CBAVD phenotype. Recent data indicate that 17.5% of healthy men with infertility due to sperm abnormalities have mutations in the CFTR gene (29) . The case of the R334W mutation in the azoospermic control group (1/6) with a defect in the spermatogenic process is in agreement with a previous report and further supports the involvement of CFTR in some cases of non-CBAVD azoospermia.
The frequencies of the 9T, 7T and 5T alleles in control and CBAVD subjects were similar to those previously described (15) . The proportion of the 5T allele was found to be increased in the CBAVD group (5/12) compared with the non-CBAVD group (0/6) as previously described (15, 16, 30, 31) .
The capacity and efficiency of the splicing of exon 9 have been further evaluated both quantitatively and qualitatively in testis by means of fluorescent RT-PCR analysis (Fig. 1) . Our results revealed that alternative splicing of exon 9 also occurs in this tissue. The proportion of E9-transcripts in testis is smaller when the number of thymidines at the T n locus in intron 8 of the CFTR gene is larger (Table 1 ), in agreement with results determined in the nasal epithelium (21, 22) . However, although the proportion of complete transcripts obtained in the 7T allele group was slightly smaller than in the 9T group, the difference was higher when compared with the 5T group. The study of alternative splicing of exon 9 was also performed in the epididymis of three patients with a 7T/7T genotype, showing that the proportion of E9-transcripts seems to be increased compared with the testis. Unfortunately, the partial or total absence of epididymis in CBAVD patients makes the obtaining of these biopsies difficult. Due to the small sample size, it was not possible to perform a statistical analysis; nevertheless, the data suggest that the efficiency of alternative splicing is different even among the tissues that constitute the genital tract. These data provide additional details about the levels of complete CFTR transcripts and phenotypic variation and could explain the greater involvement of epididymis than testis in CBAVD pathology. Previous reports corroborate our findings and support the hypothesis that the presence of the 5T allele determines different proportions of normal CFTR transcripts between organs (24, 25) . This fact may underline the different organ involvement in CF and CBAVD patients. It is well known that E9-CFTR transcripts will not produce a functional chloride channel (32) . Given that there is considerable variability in the number of complete transcripts among CBAVD individuals that carry the 5T allele, the normal phenotype will apply as long as a sufficient number of normal transcripts produces enough protein in the cells. Our results corroborate the hypothesis that the presence of a CFTR mutation in one allele and the 5T variant in the other will lead to a deficit of normal transcripts, determining the pathological involvement of organs depending on tissue-specific splicing efficiency (23, 24) .
We have also evaluated the spermatogenic status of the patients in order to elucidate the effect of alternative splicing of exon 9 of the CFTR gene. Despite the relatively small sample size, it was observed that the number of immature germ cells was within the range of normal spermatogenesis (33) and did not show quantitative differences between groups (P = 0.26). Nevertheless, cells from the later stages of the spermatogenic process were significantly reduced in number (P = 0.021) in those patients which carried the 5T allele compared with the non-5T individuals, which showed normal (∼25 elongated spermatids/ tubule) maturation of germ cells (33, 34) . Surprisingly, the presence of one or two CFTR mutations in the absence of the 5T variant was not associated with a reduction in elongated spermatids per tubule, suggesting that classic CFTR mutations are not commonly implicated in the efficiency of spermatogenesis in CBAVD patients. This fact could explain why only occasional 
CBAVD patients have been described as having decreased spermatogenesis (7).
Spermatogenesis is a complex developmental process that occurs in several phases. A large number of genes have been identified that are expressed during this process. CFTR expression in testis has been determined to occur in round spermatids in rodents (35, 36) . This fact could explain why the next step in the spermatogenic process, elongated spermatids, but not immature germ cells are affected in CF and CBAVD patients. The absence of mature spermatids and/or the presence of dysmorphic sperm in 5T CBAVD patients with insufficient normal transcripts from the CFTR gene suggests that this protein might be a factor involved in the later stages of development and maturation of germ cells. A difference in the fertilization capacity of epididymal spermatozoa between CBAVD patients testing positive and negative on CF screening has been demonstrated by other authors (37) and corroborates our hypothesis of an involvement of CFTR in the spermatogenic process. Given that CFTR expression in the testis begins at puberty, when an increase in androgens leads to the development of the later steps of spermatogenesis, this suggests that the defect in testicular tissue of male CBAVD/CF patients is of developmental origin. Therefore, there should be no embryological connection between testicular pathology and absence of the vas deferens or epididymis. The results obtained from the testicular biopsies suggest that although CF-related infertility is primarily due to obstruction or absence of the vas deferens and epididymis, a defect in the spermatogenic process is another factor to take into account which determines a more severe phenotype.
About one third of infertile men fall into the category of suffering from idiopathic defects of spermatogenesis. Given that the causes that determine this condition are unknown, pharmacological treatment has been inadequate. The application of intracytoplasmic sperm injection (ICSI) has dramatically improved the treatment of male infertility; however, it could lead to the transmission of mutations that could either perpetuate infertility or result in complications with a related genetic background. Recent data from other authors (29) and our present results suggesting a functional role of CFTR during spermatogenesis suggest the necessity of performing a CFTR analysis in azoospermic men who are going to be admitted into a fertility programme.
The relationship between CBAVD and the CFTR 5T variant has been demonstrated previously (15) . Other authors have evaluated the efficiency of the splicing mechanisms in nasal epithelium and vas deferens in the general population (23, 24) and nasal and epididymal epithelium in CBAVD and healthy patients (25) . We have demonstrated that alternative splicing of exon 9 is also seen in the testis. Elucidation of the alternative splicing mechanisms that underlie the poly(T) allele and others could be important in understanding the differences between individuals that carry the same CFTR genotype. Moreover, our data could contribute to determining the proportion of normal transcripts needed in order to re-establish a normal phenotype in the organs affected by the CF and CBAVD phenotypes.
MATERIALS AND METHODS
Subjects of study
We have studied 12 Spanish CBAVD patients (samples 7-18) and six non-CBAVD infertile individuals as controls (patients 1, 2 and 6, obstructive azoospermia; patients 3-5, secretory azoospermia). The diagnoses of CBAVD were initially suggested by absence of the vas deferens in a scrotal exploration and were confirmed by analyses of semen (volume and pH of semen, sperm count and concentrations of fructose and citrate) and transrectal ultrasound scans. Only one case (patient 10) presented a history but no clinical features of CF. In the CBAVD group, two patients (7 and 14) presented bilateral and three patients (8, 12 and 17) unilateral absence of the seminal vesicles as an associated pathology. Patient 13 also showed bilateral absence of the epididymis. In all cases, peripheral blood and testicular biopsies were obtained. Epididymal samples were obtained in three cases.
Analysis of CFTR mutations and the IVS8-6(T) n allele DNA was isolated from peripheral blood lymphocytes as previously described (38) . To characterize the samples under study, we screened mutations in the CFTR gene essentially as previously described (15, 28) . Each sample of genomic DNA was first studied for the most common CF mutations in the Spanish population, ∆F508 and G542X. Samples were then submitted to SSCA and DGGE analysis and direct automatic DNA sequencing on an ABI 373A sequencer of abnormal bands was performed. Analysis of alleles in the IVS8-6(T) n sequence of intron 8 was as described elsewhere (15) .
RT-PCR analysis
Testicular and epididymal biopsies were collected and stored at -80°C until analysis. Total RNA was isolated from tissue biopsies with Tripure solution (Boehringer Mannheim), according to the instructions provided by the manufacturer. First strand cDNA was synthesized with 5 µg RNA using random primers and Superscript II RNase H reverse transcriptase (Gibco BRL) at 42°C for 60 min. CFTR cDNA was amplified with primers located in exons 7 and 11, one of which was fluorescently labelled (23) . PCR was carried out in a GeneAmp PCR System 9600 (Perkin Elmer). Although the PCR parameters and amplimers were as described (23), studies for the validation of our RT-PCR protocol were performed as follows. PCR amplifications with 25% of the reverse transcriptase reaction mixture were carried out for a number of cycles ranging from 20 to 45, increasing at a rate of 5 cycles per amplification, in order to select the number of cycles in which the alternative CFTR transcripts could be quantified but had not reached the stationary phase. Thirty cycles was selected to perform the experiments. PCR amplifications were performed in 50 µl reaction solution and the temperature cycle conditions were: 40 s 94°C, 40 s 62°C and 60 s 72°C. In order to obtain a more accurate result and given that the different size of the products could affect their amplification rate, aliquots were withdrawn after 28, 30 and 32 cycles for each sample, to check if the fragments were equally amplified. Replicate cDNA and PCR reactions were performed for each sample. The amplified products were size fractionated by 6% acrylamide gel electrophoresis. Quantification of the fluorescently labelled products was performed with Applied Biosystem 672 Genescan software and the area of the peaks and the size of the products were obtained. PCR-amplified fragments containing exon 9 were 556 bp and those lacking exon 9 were 376 bp. The proportions of E9+ and E9-transcripts were obtained taking the sum of the areas of the peaks for E9+ and E9-as 100% (Fig. 1) .
Histological analysis
Testicular biopsies were fixed in Bouin's fluid at room temperature for 4 h, dehydrated in ascending grades of ethanol and embedded in paraffin. Sections of 5 µm were cut and stained in haematoxylin and eosin solution (Fig. 2) . Assessment of spermatogenesis was performed by quantification of specific germ cells of the spermatogenic process. The average number of spermatogoniae and elongated spermatids per tubule were calculated after analysis of at least 10-20 tubules/testis.
